-
1 Comment
Canopy Growth Corporation is currently in a long term downtrend where the price is trading 18.6% below its 200 day moving average.
From a valuation standpoint, the stock is 97.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 29.0.
Canopy Growth Corporation's total revenue rose by 23.2% to $153M since the same quarter in the previous year.
Its net income has dropped by 647.6% to $-904M since the same quarter in the previous year.
Finally, its free cash flow grew by 62.9% to $-135M since the same quarter in the previous year.
Based on the above factors, Canopy Growth Corporation gets an overall score of 3/5.
Exchange | TO |
---|---|
CurrencyCode | CAD |
ISIN | CA1380357048 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Beta | 2.14 |
---|---|
Market Cap | 488M |
PE Ratio | None |
Target Price | 3.585 |
Dividend Yield | None |
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for WEED.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025